polynoma llc
CK Life Sciences Receives FDA Clearance For PhIII Melanoma Vaccine Trial
CK Life Sciences subsidiary Polynoma LLC has received FDA clearance for Phase III clinical testing of its melanoma vaccine.
CK Life Sciences subsidiary Polynoma LLC has received FDA clearance for Phase III clinical testing of its melanoma vaccine.
